L. B. Nielsen

First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG

M. Andersson, M. Jensen, B. Ejlertsen, 2022, Breast cancer : basic and clinical research.

Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients

M. Andersson, M. Jensen, A. Knoop, 2020, Breast.

Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer

A. Gerdes, M. Jensen, M. Thomassen, 2021, British Journal of Cancer.

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study

K. Fuursted, H. Slotved, T. Dalby, 2022, European Journal of Clinical Microbiology & Infectious Diseases.

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine

S. Leung, E. Balslev, M. Jensen, 2021, Oncoimmunology.